Crossmark

Specific biomarkers for <i>C9orf72</i> <scp>FTD</scp> / <scp>ALS</scp> could expedite the journey towards effective therapies

Crossref DOI link: https://doi.org/10.15252/emmm.201707848

Published Online: 2017-05-22

Published Print: 2017-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Balendra, Rubika

Moens, Thomas G

Isaacs, Adrian M
Funding

Funding for this research was provided by:

H2020 European Research Council (648716 – C9ND)

Motor Neurone Disease Association

Wellcome Trust (107196/Z/14/Z)

Brain Research Trust

Alzheimer’s Research UK
License Information

Version of Record valid from 2017-05-22
More Information

Publication History

Published: 2017-05-22